University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
NCT Number: NCT03673644
Mobility refers to a person's purposeful movement through the environment from one place to another and can be conceptualized as a continuum from bed bound (immobility) on one extreme to making excursions to distant locations on the other extreme. Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy that can lead to gradual loss of vision in the peripheral field and central vision. Older adults with POAG have an increased risk for motor vehicle collisions and falls. Moreover, existing studies suggest that patients with POAG exhibit more postural sway while standing as measured by a balance platform and also tend to walk more slowly than those who are normally sighted and free of ocular disease. While these disturbances likely influence mobility, there has been little research directly assessing the impact of POAG on mobility. This study will assess the impact of POAG on life space (one aspect of mobility) and will determine whether difficulties with life space are associated with difficulties experienced under conditions of dim lighting.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Birmingham, Alabama, 35294, United States
Aim 1: To examine the extent of life space in older adults with POAG using the Life Space Questionnaire and to examine whether life space in persons with POAG is associated with the magnitude of visual field impairment.
Aim 2: To examine difficulties seeing under dim illumination and at night in older adults with POAG using the Low Luminance Questionnaire and to examine whether greater difficulty in seeing under dim illumination and at night is related to the magnitude of visual field loss.
Aim 3: To examine the relationship in older adults with POAG between visual problems seeing under dim illumination and at night (Low Luminance Questionnaire) and their life space (Life Space Questionnaire).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two questionnaires will be administered, one focusing on life space and the other focusing on low luminance.
Time frame: Day one
The Life Space Questionnaire is a 9-item questionnaire that assesses how much a person gets out and about and the spatial extent of the person's typical life space, i.e., what is the usual range of places in which the person engages in activities within the designated time frame. Patients are asked to respond either Yes or No.
Time frame: Day one
The results obtained on the Life Space Questionnaire will be correlated with the results of the visual field tests
Time frame: Day one
The Low Luminance Questionnaire is a 32-item questionnaire that assesses problems that involve vision under different lighting conditions or feelings about vision under different lighting conditions. The range of responses is different for different questions, with the overall pattern being that "1" means "No difficulty at all" and that increasingly higher numbers mean increasingly more difficulty.
Time frame: Day one
The results obtained on the Low Luminance Questionnaire will be correlated with the results of the visual field tests.
Time frame: Day one
The results of the Low Luminance Questionnaire will be correlated with the results of the Life Space Questionnaire
University of Alabama at Birmingham
Other
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05557058
Eye Diseases, Glaucoma
Santo Domingo, Dominican Republic
View Trial DetailsNCT05264818
Eye Diseases, Glaucoma
Paris, France
View Trial DetailsNCT03921931
Eye Diseases, Geographic Atrophy
Vienna, State of Vienna, Austria
View Trial DetailsNCT03651336
Cataract, Eye Diseases
Aachen, Germany
View Trial Details